Medical News

RSS

Moving quickly across slippery surfaces reduces chances of falling

Biomechanics researchers Timothy Higham of Clemson University and Andrew Clark of the College of Charleston conclude that moving quickly in a forward, firm-footed stance across a slippery surface is less likely to lead to a fall than if you move slowly. Approaching a slippery surface slowly hinders the necessary task of shifting the center of mass forward once foot contact is made.

25 Mar 2011

Countries ban imports of Japanese food as radiation leak continues

Countries worldwide on Thursday banned or limited food imports from Japan, as radioactive steam continued to leak from the Fukushima nuclear plant damaged by the March 11 earthquake and tsunami, Agence France-Presse reports.

25 Mar 2011

New Pediatric Physical Medicine and Rehabilitation Service at NewYork-Presbyterian Hospital

NewYork-Presbyterian Hospital has established a Pediatric Physical Medicine and Rehabilitation Service, led by Dr. Heakyung Kim. In this role, Dr. Kim will provide specialized care for children with neuromuscular disorders and other special needs at the Hospital's two major centers for pediatric care: Morgan Stanley Children's Hospital at NewYork-Presbyterian Hospital/Columbia University Medical Center and the Komansky Center for Children's Health at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

25 Mar 2011

Covaris launches Bench-top SF220 Formulation Processing System

Covaris Incorporated today announced the introduction of the Bench-top SF220 High Performance Formulation Processing System.

25 Mar 2011

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

Chronic Obstructive Pulmonary Disease (COPD) is a major cause for hospital stays and emergency room visits across Canada and researchers say minimizing exacerbations or flare-ups of the disease can go a long way to reducing hospitalizations.

25 Mar 2011

Polls showcase national divisions, opinions about health law

A year has passed and polls still highlight the steadiness in the public rift on the health law.

25 Mar 2011

AssureRx closes $11 million Series B financing

AssureRx Health, Inc. today announced the closing of an $11 million Series B financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug and the right dose for individual neuropsychiatric patients, will use the funds to expand direct sales and marketing for its first product, GeneSightRx®, and for second generation product development activities.

25 Mar 2011

Merck to return rights for betrixaban to Portola

Portola Pharmaceuticals and Merck, known as MSD outside the United States and Canada, today announced that Merck plans to return to Portola all rights for betrixaban, an investigational oral Factor Xa inhibitor anticoagulant being evaluated for the prevention of stroke in patients with atrial fibrillation (SPAF). This decision was made following a review of Merck's investigational portfolio.

25 Mar 2011

IOM offers standards to develop clinical practice guidelines

Modern Healthcare reports that the Institute of Medicine has issued eight recommended standards to develop clinical practice guidelines. Meanwhile, it also reports on the findings of a national survey regarding medical mistakes.

25 Mar 2011

Qualifacts CareLogic Enterprise achieves Complete EHR certification

Qualifacts Systems Inc. announced at the kickoff of its 2011 Users' Conference that CareLogic Enterprise is 2011/2012 compliant and was certified as a Complete EHR on March 22, 2011, by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services.

25 Mar 2011

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

25 Mar 2011

Biostar fourth quarter revenues increase 65.7% to $28.2 million

Biostar Pharmaceuticals, Inc., Xianyang-based manufacturer of a leading PRC over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced financial results for the fourth quarter and full year ended December 31, 2010.

25 Mar 2011

First Edition: March 25, 2011

In his latest Kaiser Health News column, John Goodman writes: "As governors across the land struggle with fiscal pressures and pepper the federal government with requests to scale back Medicaid - many people are losing sight of the fact that health care reform requires a huge expansion of Medicaid".

25 Mar 2011

'Consent rituals' cause life-threatening delays

Current rules requiring researchers to obtain consent for patients to take part in clinical trials in emergency situations are causing life-threatening delays to treatment, experts have argued.

25 Mar 2011

Graceway receives FDA approval for Zyclara Cream to treat genital warts

Graceway Pharmaceuticals announced today that the Food and Drug Administration has approved Zyclara Cream for the treatment of external genital and perianal warts in patients 12 years of age and older.

25 Mar 2011

New study finds 74.8% increase in hospital emergency visits due to Ecstasy use

A new national study indicates that the number of hospital emergency visits involving the illicit drug Ecstasy increased from 10,220 in 2004 to 17,865 visits in 2008 - a 74.8 percent increase.

25 Mar 2011

Experts to address worldwide impact of Alzheimer's disease at ADI conference

On Sunday March 27 leaders at the 26th Annual Conference of Alzheimer's Disease International will challenge the World Health Organization and countries around the world to take action on the dramatic surge in the global incidence of Alzheimer's disease and dementia.

25 Mar 2011

Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates

Protelos has significantly greater bone-forming activity than the commonly prescribed bisphosphonate, alendronate, according to results of the largest-ever biopsy study in post-menopausal women presented today at the European Congress on Osteoporosis and Osteoarthritis in Valencia.

25 Mar 2011

Study finds that 25% of health messages in school text books lack scientific evidence

Most school text books contain messages about health, but 24.6% of these are not based on any scientific evidence, according to a study by the Knowledge Management Unit at Baza Hospital (Granada), published in the journal BMC Public Health.

25 Mar 2011

Experts to discuss on neuroscience of emotion-related disorders

Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?

25 Mar 2011